These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 31004915)

  • 1. Previous glucocorticoid treatment in childhood and adolescence is associated with long-term differences in subcortical grey matter volume and microstructure.
    Holm SK; Madsen KS; Vestergaard M; Born AP; Paulson OB; Siebner HR; Uldall P; Baaré WFC
    Neuroimage Clin; 2019; 23():101825. PubMed ID: 31004915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total brain, cortical, and white matter volumes in children previously treated with glucocorticoids.
    Holm SK; Madsen KS; Vestergaard M; Paulson OB; Uldall P; Siebner HR; Born AP; Baaré WFC
    Pediatr Res; 2018 Apr; 83(4):804-812. PubMed ID: 29252981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of subcortical grey matter abnormalities in patients with MRI-negative cortical epilepsy determined through structural and tensor magnetic resonance imaging.
    Peng SJ; Harnod T; Tsai JZ; Ker MD; Chiou JC; Chiueh H; Wu CY; Hsin YL
    BMC Neurol; 2014 May; 14():104. PubMed ID: 24885823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
    Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK
    JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid treatment for non-cerebral diseases in children and adolescents is associated with differences in uncinate fasciculus microstructure.
    Vestergaard M; Baaré WFC; Holm SK; Madsen CG; Paulson OB; Born AP; Uldall P; Siebner HR; Madsen KS
    Pediatr Res; 2022 Mar; 91(4):879-887. PubMed ID: 33790412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcortical grey matter changes in juvenile myoclonic epilepsy.
    Kim JH; Kim JB; Suh SI; Kim DW
    Neuroimage Clin; 2018; 17():397-404. PubMed ID: 29159052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
    Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
    Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anatomical and diffusion MRI of deep gray matter in pediatric spina bifida.
    Ware AL; Juranek J; Williams VJ; Cirino PT; Dennis M; Fletcher JM
    Neuroimage Clin; 2014; 5():120-7. PubMed ID: 25057465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grey matter volumes in treatment naïve vs. chronically treated children with attention deficit/hyperactivity disorder: a combined approach.
    Villemonteix T; De Brito SA; Kavec M; Balériaux D; Metens T; Slama H; Baijot S; Mary A; Peigneux P; Massat I
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1118-27. PubMed ID: 25934396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder.
    Castellanos FX; Lee PP; Sharp W; Jeffries NO; Greenstein DK; Clasen LS; Blumenthal JD; James RS; Ebens CL; Walter JM; Zijdenbos A; Evans AC; Giedd JN; Rapoport JL
    JAMA; 2002 Oct; 288(14):1740-8. PubMed ID: 12365958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity, Brain Volume, and White Matter Microstructure at MRI: A Cross-sectional UK Biobank Study.
    Dekkers IA; Jansen PR; Lamb HJ
    Radiology; 2019 Jun; 291(3):763-771. PubMed ID: 31012815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative analysis of early-stage Alzheimer's disease and normal aging with automatic segmentation technique in subcortical gray matter structures: a multicenter in vivo MRI volumetric and DTI study.
    Li YD; He HJ; Dong HB; Feng XY; Xie GM; Zhang LJ
    Acta Radiol; 2013 Dec; 54(10):1191-200. PubMed ID: 23878359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grey matter volume in adolescents with anorexia nervosa and associated eating disorder symptoms.
    Martin Monzon B; Henderson LA; Madden S; Macefield VG; Touyz S; Kohn MR; Clarke S; Foroughi N; Hay P
    Eur J Neurosci; 2017 Oct; 46(7):2297-2307. PubMed ID: 28833732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive deep gray matter volume reductions in children and adolescents with fetal alcohol spectrum disorders.
    Nardelli A; Lebel C; Rasmussen C; Andrew G; Beaulieu C
    Alcohol Clin Exp Res; 2011 Aug; 35(8):1404-17. PubMed ID: 21575012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Grey Matter Volume is Reduced in Amateur Boxers as Compared to Healthy Age-matched Controls.
    Zidan M; Jesser J; Herweh C; Jost J; Heiland S; Meyding-Lamadé U; Bendszus M; Haehnel S
    Clin Neuroradiol; 2023 Jun; 33(2):475-482. PubMed ID: 36525030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of deep gray matter volume across the human lifespan.
    Narvacan K; Treit S; Camicioli R; Martin W; Beaulieu C
    Hum Brain Mapp; 2017 Aug; 38(8):3771-3790. PubMed ID: 28548250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early life predictors of brain development at term-equivalent age in infants born across the gestational age spectrum.
    Thompson DK; Kelly CE; Chen J; Beare R; Alexander B; Seal ML; Lee K; Matthews LG; Anderson PJ; Doyle LW; Spittle AJ; Cheong JLY
    Neuroimage; 2019 Jan; 185():813-824. PubMed ID: 29660514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcortical grey matter changes in untreated, early stage Parkinson's disease without dementia.
    Lee HM; Kwon KY; Kim MJ; Jang JW; Suh SI; Koh SB; Kim JH
    Parkinsonism Relat Disord; 2014 Jun; 20(6):622-6. PubMed ID: 24703894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling age, puberty and testosterone effects on subcortical brain development across adolescence.
    Wierenga LM; Bos MGN; Schreuders E; Vd Kamp F; Peper JS; Tamnes CK; Crone EA
    Psychoneuroendocrinology; 2018 May; 91():105-114. PubMed ID: 29547741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.